We are live on ! Find out more
ONC

BeOne Medicines Ltd

221 hedge funds and large institutions have $8.11B invested in BeOne Medicines Ltd in 2019 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 66 increasing their positions, 76 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 19

32% more capital invested

Capital invested by funds: $6.12B → $8.11B (+$1.99B)

13% more funds holding

Funds holding: 196221 (+25)

0.13% less ownership

Funds ownership: 6.4%6.27% (-0.13%)

10% less funds holding in top 10

Funds holding in top 10: 109 (-1)

13% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 76

72% less call options, than puts

Call options by funds: $16.8M | Put options by funds: $59.2M

Holders
221
Holders Change
+25
Holders Change %
+12.76%
% of All Funds
4.35%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.18%
New
50
Increased
66
Reduced
76
Closed
19
Calls
$16.8M
Puts
$59.2M
Net Calls
-$42.3M
Net Calls Change
-$37.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
151
Principal Financial Group
Iowa
$468K -$7.48K -45 -2%
II
152
IFM Investors
Australia
$440K -$44.7K -269 -9%
Teacher Retirement System of Texas
153
Teacher Retirement System of Texas
Texas
$434K -$1.95M -11,729 -82%
AIM
154
Achmea Investment Management
Netherlands
$429K +$430K +2,591 New
CIBC Asset Management
155
CIBC Asset Management
Ontario, Canada
$425K +$55K +331 +15%
Caisse de Depot et Placement du Quebec (CDPQ)
156
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$414K +$133K +800 +47%
CG
157
Cutler Group
California
$414K +$283K +1,702 +214%
Dimensional Fund Advisors
158
Dimensional Fund Advisors
Texas
$406K -$21.3K -128 -5%
Squarepoint
159
Squarepoint
New York
$406K +$407K +2,450 New
MIM
160
MetLife Investment Management
New Jersey
$398K
Jennison Associates
161
Jennison Associates
New York
$366K +$367K +2,206 New
FAF
162
Första AP-fonden
Sweden
$365K +$366K +2,200 New
Daiwa Securities Group
163
Daiwa Securities Group
Japan
$353K -$4.82K -29 -1%
SMDAM
164
Sumitomo Mitsui DS Asset Management
Japan
$347K +$831 +5 +0.2%
SEC
165
Seven Eight Capital
New York
$329K +$329K +1,983 New
CGH
166
Crossmark Global Holdings
Texas
$323K -$8.31K -50 -3%
SCM
167
Stevens Capital Management
Pennsylvania
$309K +$309K +1,862 New
Ensign Peak Advisors
168
Ensign Peak Advisors
Utah
$307K +$307K +1,850 New
SSA
169
Schonfeld Strategic Advisors
New York
$301K +$301K +1,813 New
TC
170
TwinBeech Capital
New York
$297K +$298K +1,793 New
State Board of Administration of Florida Retirement System
171
State Board of Administration of Florida Retirement System
Florida
$293K +$294K +1,770 New
Toronto Dominion Bank
172
Toronto Dominion Bank
Ontario, Canada
$282K
NIT
173
NumerixS Investment Technologies
British Columbia, Canada
$282K +$114K +686 +68%
MLICM
174
Metropolitan Life Insurance Company (MetLife)
New York
$282K
RJA
175
Raymond James & Associates
Florida
$280K +$281K +1,692 New

ONC Hedge Fund Activity: Q4 2019 in Review

221 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q4 2019, worth a combined $8.11B — up 32% from $6.12B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new ONC positions and 19 closed out — a net gain of 31 holders — while 66 added to existing stakes and 76 trimmed.

The largest buyer was Capital International Investors, adding an estimated $166M. The largest seller was Myriad Asset Management, exiting entirely with an estimated $120M sold.

  • 221 institutional investors held BeOne Medicines Ltd (ONC) as of Q4 2019, up from 196 in Q3 2019.
  • Funds reported $8.11B of BeOne Medicines Ltd stock for Q4 2019, up 32% quarter-over-quarter.
  • 50 funds opened new BeOne Medicines Ltd positions in Q4 2019 and 19 closed out, a net change of +31 holders.
  • The largest BeOne Medicines Ltd buyer in Q4 2019 was Capital International Investors, an estimated $166M added.
  • The largest BeOne Medicines Ltd seller in Q4 2019 was Myriad Asset Management, an estimated $120M sold.

Based on aggregated 13F filings for Q4 2019.